| 000 | 01334 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515013747.0 | ||
| 264 | 0 | _c20070125 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0304-3835 | ||
| 024 | 7 |
_a10.1016/j.canlet.2005.12.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Bi-Xing | |
| 245 | 0 | 0 |
_aCell cycle inhibition by an anti-cyclin D1 antibodychemically modified for intracellular delivery. _h[electronic resource] |
| 260 |
_bCancer letters _cNov 2006 |
||
| 300 |
_a71-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aCyclin D1 _ximmunology |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aHT29 Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNIH 3T3 Cells _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xpathology |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aErlanger, Bernard F | |
| 773 | 0 |
_tCancer letters _gvol. 244 _gno. 1 _gp. 71-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2005.12.011 _zAvailable from publisher's website |
| 999 |
_c16057039 _d16057039 |
||